The Binding Affinities of Serum Proteins to Nanoparticles

Nanoparticles can be coated with targeting ligands to deliver medical agents to specific cells. Serum protein adsorption affects the binding of nanoparticles to target cells. We hypothesized that serum proteins and target receptors compete for binding to nanoparticles. We tested the serum protein binding affinity of 251 nanoparticle designs. Here, we discovered that the binding affinities of serum proteins and receptors to a nanoparticle determine whether it can bind to target cells. We developed and validated a quantitative metric, the binding ratio, to identify nanoparticle designs that can bind to targets in serum with 90% sensitivity and 88% specificity. Using the binding ratio as a numerical guideline for nanoparticle design enabled us to improve the efficiency of nanoparticle binding to target cellular receptors.

Authors

Institutions

Publication Details

Journal
Journal of the American Chemical Society
Published
2025-06-09
DOI
https://doi.org/10.1021/jacs.5c02576
Citations
5
Primary Topic
Nanoparticle-Based Drug Delivery
Type
article
Field-Weighted Citation Impact
2.99

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The Binding Affinities of Serum Proteins to Nanoparticles

Guanyou Lin, Benjamin Stordy, Warren C. W. Chan, Colin Blackadar et al.
5 citations
Journal of the American Chemical Society
Nanoparticle-Based Drug Delivery
2.99
article

The Binding Affinities of Serum Proteins to Nanoparticles

Guanyou Lin, Benjamin Stordy, Warren C. W. Chan, Colin Blackadar, Neil P. King, Wei Yang, Rashmi Ravichandran, Luis Ricardez‐Sandoval, Derrick R. Hicks, Gabriel D. Patrón, Mikhail G. Shapiro, Anthony J. Tavares, David A. Baker, Bill Ling, Zahra Sepahi, Alexander D. Goodson, Ayden Malekjahani, Miqin Zhang
article en
5 citations

Abstract

Nanoparticles can be coated with targeting ligands to deliver medical agents to specific cells. Serum protein adsorption affects the binding of nanoparticles to target cells. We hypothesized that serum proteins and target receptors compete for binding to nanoparticles. We tested the serum protein binding affinity of 251 nanoparticle designs. Here, we discovered that the binding affinities of serum proteins and receptors to a nanoparticle determine whether it can bind to target cells. We developed and validated a quantitative metric, the binding ratio, to identify nanoparticle designs that can bind to targets in serum with 90% sensitivity and 88% specificity. Using the binding ratio as a numerical guideline for nanoparticle design enabled us to improve the efficiency of nanoparticle binding to target cellular receptors.

Journal of the American Chemical SocietyVol. 147(24)
California Institute of Technology (US), Howard Hughes Medical Institute (US), University of Waterloo (CA), Nanyang Technological University (SG), University of Toronto (CA), University of Washington (US), National Institute for Nanotechnology (CA), Division of Chemistry (US), Institute of Biomedical Science (GB), Imperial College London (GB)
Bill and Melinda Gates Foundation, Kuni Foundation, National Institutes of Health, Natural Sciences and Engineering Research Council of Canada
Openalex Percentile: Top 9%
Nanoparticle-Based Drug Delivery
2.99
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.